BioMarin Pharmaceutical, Inc. (BMRN)
59.43
+0.44
(+0.75%)
USD |
NASDAQ |
Dec 31, 13:20
BioMarin Pharmaceutical Price: 59.43 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.24 |
| Gilead Sciences, Inc. | 123.12 |
| Merck & Co., Inc. | 105.60 |
| AbbVie, Inc. | 229.91 |
| Bristol Myers Squibb Co. | 54.18 |
Price Related Metrics
| PE Ratio | 22.27 |
| PS Ratio | 3.767 |
| PEG Ratio | 0.3668 |
| Price to Book Value | 1.885 |
| Price to Free Cash Flow | 14.07 |
| Earnings Yield | 4.49% |
| Market Cap | 11.42B |
| PEGY Ratio | 0.3668 |
| Operating PE Ratio | 13.58 |
| Normalized PE Ratio | 16.65 |